Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Healthcare stocks are on a hot streak, and Wall Street thinks politics is a big reason why. Investors appear to be pricing in growing odds of Democrats winning one or both chambers of Congress in November, which could roll back steep Medicaid cuts from last year's spending bill. Hospitals, insurers, and pharma giants are all riding the wave.
Healthcare stocks have been quietly outperforming the broader market, and analysts say midterm election expectations are a major driver. The S&P 500's health care sector has climbed over 9% in the last three months alone — the second-best performance among the index's 11 sectors. Hospital chains, insurers, and big pharma names like Eli Lilly, Merck, and AbbVie have all posted notable gains.
The rally appears tied to investor optimism that a Democratic takeover of Congress could slow or reverse the Medicaid reimbursement cuts baked into President Trump's 2025 "One Big, Beautiful Bill Act." Analysts at Jefferies note that "investor sentiment has turned notably bullish for hospitals," while Citi flagged that a Democratic sweep could bring "increased health care subsidies and delayed health care cuts."
That said, the picture isn't entirely rosy. Analysts at TD Securities caution that even a full Democratic sweep may not translate into meaningful reform — a more progressive Congress could push the agenda further left, reducing the chances of bipartisan compromise and potentially complicating any health care legislation.
By the Numbers:
Why it matters: Federal health spending policy — particularly Medicaid — has enormous downstream effects on hospitals, insurers, and patients. Investors are essentially placing bets on election outcomes that could reshape the financial landscape of U.S. healthcare for years to come.
